Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
2.600
-0.220 (-7.80%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Virax Biolabs Group Market Cap
Virax Biolabs Group has a market cap or net worth of $2.07 million as of September 2, 2026. Its market cap has decreased by -21.22% in one year.
Market Cap
2.07M
Enterprise Value
-4.03M
1-Year Change
-21.22%
Ranking
Category
Stock Price
$2.60
ChartMarket Cap Chart
Since the IPO on July 21, 2022, Virax Biolabs Group's market cap has decreased from $207.01M to $2.07M, a decrease of -99.00%. That is a compound annual growth rate of -67.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 2.07M | -19.28% |
| Dec 31, 2025 | 2.57M | -73.72% |
| Dec 31, 2024 | 9.77M | 269.38% |
| Dec 29, 2023 | 2.64M | -71.76% |
| Dec 30, 2022 | 9.36M | -95.48% |
| Jul 21, 2022 | 207.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curis | 3.11M |
| Propanc Biopharma | 3.08M |
| Genprex | 3.04M |
| Matinas BioPharma Holdings | 2.90M |
| Clearmind Medicine | 2.88M |
| Jupiter Neurosciences | 2.73M |
| Onconetix | 2.48M |
| Oragenics | 2.30M |